virus
close
associ
acut
chronic
wheez
especi
true
children
studi
involv
outpati
children
present
emerg
depart
identifi
virusand
hostspecif
factor
modifi
risk
virusinduc
wheez
establish
respiratori
syncyti
virus
rsv
caus
wheez
episod
infanc
wherea
rhinovirus
identifi
major
caus
acut
exacerb
asthma
children
older
year
age
number
factor
influenc
risk
virusinduc
wheez
infanc
includ
genet
reduc
lung
size
exposur
tobacco
smoke
children
older
children
allergi
viral
infect
synergist
promot
wheez
issu
journal
heymann
et
al
extend
understand
subject
welldesign
studi
viral
infect
allergi
wheez
larg
group
hospit
children
casecontrol
studi
involv
children
age
admit
hospit
wheez
equal
number
nonwheez
control
children
includ
respiratori
ill
wheez
nasal
lavag
specimen
analyz
respiratori
virus
sera
analyz
allergenspecif
ige
find
casecontrol
studi
profoundli
influenc
select
control
subject
studi
control
group
match
term
age
sex
importantli
month
admiss
strong
influenc
incid
specif
viral
infect
moreov
studi
conduct
period
encompass
season
variabl
viral
epidemiolog
includ
except
high
rate
particip
elig
subject
take
part
result
studi
design
help
defin
broad
stroke
spectrum
children
sever
wheez
ill
infanc
viral
infect
caus
wheez
ill
allergi
littl
influenc
process
rsv
particular
isol
much
often
wheez
group
compar
control
group
expect
season
infect
sharpli
confin
coldweath
month
notabl
studi
high
preval
ill
one
viru
detect
find
testament
sensit
viral
diagnost
use
studi
underscor
ubiquit
exposur
virus
age
group
confirm
previou
report
indic
infant
multipl
viral
infect
tend
quit
ill
remark
rhinovirus
main
pathogen
associ
wheez
infanc
time
year
rhinovirus
like
isol
wheez
control
subject
although
differ
dramat
observ
rsv
suggest
substanti
role
hostspecif
factor
determin
wheez
rhinovirus
infant
wheez
rhinovirus
gener
associ
rel
mild
ill
strain
rhinoviru
simpli
virul
rhinovirusinduc
wheez
infanc
indic
problem
host
although
clinic
import
question
yet
fulli
resolv
evid
infant
wheez
rhinoviru
infect
inde
differ
term
risk
factor
prognosi
perhap
even
respons
treatment
exampl
previou
studi
indic
immunolog
factor
defici
type
type
ifn
respons
lead
frequent
viral
infect
sever
viral
infect
addit
kotaniemisyrjanen
et
al
finland
perform
viral
diagnost
nasal
secret
infant
hospit
wheez
ill
evalu
children
allergi
asthma
year
later
time
initi
visit
children
wheez
rhinoviru
infect
like
atop
dermat
followup
visit
wheez
rhinovirus
infanc
increas
risk
asthma
compar
children
wheez
virus
princip
rsv
final
preliminari
indic
know
viru
caus
wheez
episod
infanc
could
import
guid
therapi
abstract
present
recent
american
academi
allergi
asthma
immunolog
meet
jartti
et
al
report
administr
oral
prednisolon
wheez
infant
hospit
result
strike
benefit
infect
rhinovirus
enterovirus
rsvinfect
infant
collect
studi
indic
host
factor
relat
lung
immun
system
help
determin
sever
rhinoviru
infect
risk
wheez
moreov
caus
virusinduc
wheez
infanc
might
import
factor
determin
respons
therapi
longterm
prognosi
new
data
present
heymann
et
al
viral
infect
also
import
caus
wheez
older
children
year
age
season
pathogen
differ
peak
hospit
occur
fall
observ
studi
rhinovirus
often
detect
age
group
author
confirm
previou
observ
allerg
sensit
viral
infect
independ
synergist
risk
factor
develop
wheez
extend
observ
sever
exacerb
lead
hospit
appear
studi
conduct
adult
sensit
allergen
exposur
togeth
requir
synergist
effect
viral
infect
addit
studi
need
confirm
find
determin
whether
consequ
allergeninduc
inflamm
airway
respons
factor
virus
detect
hospit
children
age
year
age
year
lower
previou
recoveri
rate
estim
outpati
studi
remark
season
distribut
wheez
virusposit
virusneg
children
nearli
ident
octob
peak
hospit
group
close
correspond
return
school
consequ
common
cold
season
season
coincid
suggest
virusneg
episod
fact
caus
viral
infect
sever
potenti
barrier
optim
viral
detect
even
sensit
viral
diagnost
use
studi
first
previou
studi
found
peak
viral
shed
nasal
secret
earli
stage
infect
children
hospit
wheez
typic
lag
behind
onset
cold
symptom
coupl
day
like
past
optim
time
viral
diagnost
second
sever
new
respiratori
virus
discov
sinc
trial
conduct
includ
metapneumoviru
new
coronavirus
final
larg
number
rhinoviru
serotyp
decad
catalogu
new
isol
virologist
quit
count
although
current
pcr
technolog
much
sensit
viral
cultur
diagnos
rhinoviru
infect
unlik
singl
set
primer
detect
known
serotyp
let
alon
yet
discov
despit
limit
determin
precis
number
infect
children
littl
doubt
increas
age
rate
viral
isol
gradual
diminish
preval
allerg
sensit
increas
greater
number
exacerb
occur
independ
viral
infect
caus
sever
acut
wheez
episod
children
detect
virus
author
suggest
allergen
exposur
like
culprit
dust
mite
allergi
close
associ
risk
wheez
fact
data
medic
center
demonstr
level
dust
mite
protein
although
perenni
allergen
vari
somewhat
season
maxim
late
summer
earli
fall
alternaria
speci
import
aeroallergen
time
period
alternaria
speci
allergi
risk
factor
persist
childhood
asthma
also
associ
acut
sever
exacerb
anoth
factor
consid
pollut
like
indoor
environ
particularli
presenc
tobacco
smoke
import
rel
small
citi
charlottesvil
among
wheez
infant
trend
toward
increas
exposur
matern
smoke
comprehens
natur
welldesign
studi
relat
season
age
group
viral
pathogen
detect
help
clarifi
relationship
virus
wheez
ill
childhood
although
crosssect
studi
limit
abil
predict
natur
histori
viral
wheez
ill
consid
togeth
multitud
clinic
studi
coher
stori
begin
emerg
wheez
infanc
predominantli
viral
risk
factor
includ
relat
lung
immun
system
environ
allergi
assum
progress
greater
role
case
primari
role
sever
exacerb
second
decad
life
beyond
document
individu
risk
factor
result
develop
theme
isol
viral
respiratori
infect
exposur
airborn
allergen
pollut
rather
unlik
precipit
hospit
caus
asthma
combin
noxiou
stimuli
like
exert
effect
distinct
mechan
pathway
might
gener
requir
produc
sever
episod
wheez
airway
obstruct
model
import
implic
regard
treatment
although
forese
futur
might
difficult
reduc
preval
common
viral
infect
rhinovirus
rsv
mani
risk
factor
includ
environment
exposur
allerg
airway
inflamm
might
amen
chang
least
prevent
treatment
